about
P184
The eNanoMapper database for nanomaterial safety informationThe ToxBank Data Warehouse: Supporting the Replacement of In Vivo Repeated Dose Systemic Toxicity TestingComputational toxicology using the OpenTox application programming interface and BioclipseThe first eNanoMapper prototype: A substance database to support safe-by-designThe Janus face of alcohol dehydrogenase 3Cancer Biology, Toxicology and Alternative Methods Development Go Hand-in-HandA transcriptomics data-driven gene space accurately predicts liver cytopathology and drug-induced liver injuryCytotoxicity, thiol depletion and inhibition of O6-methylguanine-DNA methyltransferase by various aldehydes in cultured human bronchial fibroblasts.High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.CD44 expression in oro-pharyngeal carcinoma tissues and cell linesFibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma.MAML1 acts cooperatively with EGR1 to activate EGR1-regulated promoters: implications for nephrogenesis and the development of renal cancer.Modelling of normal and premalignant oral tissue by using the immortalised cell line, SVpgC2a: a review of the value of the model.Comparative hazard characterization in food toxicology.Consumption of Red/Processed Meat and Colorectal Carcinoma: Possible Mechanisms Underlying the Significant Association.Differentiation-promoting culture of competent and noncompetent keratinocytes identifies biomarkers for head and neck cancer.Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines.Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture.Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma.RDFIO: extending Semantic MediaWiki for interoperable biomedical data management.YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer.Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models.Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines.Arsenic alters global histone modifications in lymphocytes in vitro and in vivo.Reduction of S-nitrosoglutathione by alcohol dehydrogenase 3 is facilitated by substrate alcohols via direct cofactor recycling and leads to GSH-controlled formation of glutathione transferase inhibitors.Microarray assessment of fibronectin, collagen and integrin expression and the role of fibronectin-collagen coating in the growth of normal, SV40 T-antigen-immortalised and malignant human oral keratinocytes.Arsenic-induced suppression of kidney cell proliferation and the transcriptional coregulator MAML1.Formaldehyde dehydrogenase: beyond phase I metabolism.A data fusion pipeline for generating and enriching Adverse Outcome Pathway descriptionsMedium-chain fatty acids and glutathione derivatives as inhibitors of S-nitrosoglutathione reduction mediated by alcohol dehydrogenase 3.Enriching Nanomaterials Omics Data: An Integration Technique to Generate Biological DescriptorsChapter 11. Computational Modelling of Biological Responses to Engineered NanomaterialsRequirement of apoptotic protease-activating factor-1 for bortezomib-induced apoptosis but not for Fas-mediated apoptosis in human leukemic cells.Interactive predictive toxicology with Bioclipse and OpenToxSharing dose response data and analysis across the SEURAT-1 clusterA novel infrastructure for chemical safety predictions with focus on human healthThe eNanoMapper database for nanomaterial safety informationIntegrated analysis of in vitro data and the adverse outcome pathway framework for prioritization and regulatory applications: An exploratory case study using publicly available data on piperonyl butoxide and liver modelseNanoMapper – A database and ontology framework for design and safety assessment of nanomaterialsIntegrated analysis of in vitro data and the adverse outcome pathway framework for prioritization and regulatory applications: An exploratory case study using publicly available data on piperonyl butoxide and liver models
P50
Q24188395-5b448e92-49d5-a97a-154f-754504559a21Q27062617-2a46a48d-483f-a27f-488a-421159476ce6Q27134787-b46bf825-4cea-a05e-6d08-13f1d4b5d5c9Q27701165-5c270141-4b7d-af5d-00cc-f198d6d5e9d5Q28302063-CDCEDF8A-5951-4E82-9B57-9A73DF1727B0Q28549191-55aa527a-40e8-e7fc-f52f-0b3a25dec8adQ31724476-544806a8-4e37-52e5-06e1-171d77a86d31Q31958359-96b752c9-40a1-5d15-95d4-50d7be1a2df0Q33507489-D83D6816-CE02-4D12-BB3D-070968C01C65Q34126560-1641662F-BA99-45E0-AEE6-91FCC55B260FQ34142365-9F3B66CD-08FF-4291-B01F-79E3319CC8A7Q34430565-ACA5216A-03C2-47AD-B17C-CB01A4845521Q36009921-7EE51BA1-D632-41A9-ABAC-91B889869C37Q37543221-A6054AB4-6CA6-4F55-BCEB-FB0E7BB08BDAQ38409303-E404C524-E7B5-412C-9900-6CA1FD9DA571Q38499568-828AB24D-D581-48D9-9E33-BCAB54B3216CQ38510163-0E28E582-6FCA-47B0-82B8-46E450F9B1B8Q38513858-37EFAD92-0E15-4AC0-B753-85EF551496DCQ38515690-C319298E-B925-477E-92D7-048D486C3853Q38599953-8601db8e-4cb5-4a07-f48b-df1bc3c4ef1bQ38978179-9C6802FF-ABBC-4F87-94A4-97052E36A911Q39458550-0F5F3C49-D33B-400C-9952-44F12C3F0616Q39560861-8E6D2581-A73E-40AE-8F12-1236C085C566Q39778013-65555AA0-9CE7-4165-8EB0-BB524FE1F394Q39991981-B9E2503C-66C7-48DD-9ACA-C8F279C6B84CQ40488770-CF739846-95B9-4D88-9D0D-5A506F414E22Q42707120-971DBAF1-2E2D-4E55-B0B1-13429D05A5BCQ43229202-67D597E2-EE56-46DD-A97C-758E68D97BAAQ43253348-4afedc72-45ac-6c36-dce3-124ecf89fa50Q46018694-7C0236D1-7F29-47EE-8BA1-9F35CDD27786Q52263227-7FF7A9EB-886C-4194-838F-B41B0409396FQ52263552-4acf56c8-4758-2ffb-3e22-08b2c76502e4Q53137734-B6352114-A987-4777-8FA5-7394DD502E3DQ54405113-20dfcdc9-4fb0-7ece-d568-6f915f88d8ebQ56160807-C3904A00-B944-44A5-95D3-1B5DEFC4C2CBQ56914156-16714510-DB04-4A11-940D-E9BBA2B7721BQ56919959-B5845B31-C919-4451-9DB4-20013DA73D59Q56976500-F3166B84-14BB-4839-A4C3-F19B6FA0E51DQ56976520-73AADCD8-13CA-412E-B640-1498798B4066Q57159884-D3146574-1984-4B27-B0A8-27B52CEB17B1
P50
description
Swedish/Finnish researcher
@en
wetenschapper
@nl
name
Roland Grafström
@ast
Roland Grafström
@en
Roland Grafström
@es
Roland Grafström
@nl
Roland Grafström
@sv
type
label
Roland Grafström
@ast
Roland Grafström
@en
Roland Grafström
@es
Roland Grafström
@nl
Roland Grafström
@sv
altLabel
R Grafström
@en
R.C. Grafström
@en
Roland C Grafström
@en
Roland C. Grafström
@en
prefLabel
Roland Grafström
@ast
Roland Grafström
@en
Roland Grafström
@es
Roland Grafström
@nl
Roland Grafström
@sv
P106
P1416
P185
P21
P31
P496
0000-0002-7483-1347
P569
2000-01-01T00:00:00Z